References
- Maschmeyer G, Donnely JP. How to manage lung infiltrates in adult suffering from haematological malignancies outside allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2016;173:179–189.
- Sampsonas F, Kontoyiannis DP, Dickey BF, et al. Performance of a standardized bronchoalveolar lavage protocol in a comprehensive cancer center: a prospective 2-year study. Cancer. 2011;117:3424–3433.
- Vehreschild JJ, Böhme A, Buchheidt A, et al. A double-blind trial on prophylactic voriconazole or placebo during induction chemotherapy for acute myelogenous leukaemia. J Infect. 2007;55:445–449.
- De Pauw B, Walsh TJ, Donnely JP, et al. Revised definitions of invasive fungal disease from the European Organization for Reasearch and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group. Clin Infect Dis. 2008;46:1813–1821.
- Yamakami Y, Hashimoto A, Yamagata E, et al. Evaluation of PCR for detection of DNA specific for Aspergillus species in sera of patients with various forms of pulmonary aspergillosis. J Clin Microbiol. 1998;36:3619–3623.
- Lindsley MD, Hurst SF, Iqbal NJ, et al. Rapid identification of dimorphic and yeast-like fungal pathogens using specific DNA probes. J Clin Microbiol. 2001;39:3505–3511.
- Hansell DM, Bankier AA, MacMahon H, et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008;246:697–722.
- Maccioni F, Vetere S, De Felice C, et al. Pulmonary fungal infections in patients with acute myeloid leukaemia: is it the time to revise the radiological diagnosti criteria? Mycoses. 2016;59:357–364.
- Nucci M, Nouér SA, Grazziutti M, et al. Probable invasive aspergillosis without prespecified radiologic findings: proposal of inclusion of a new category of aspergillosis and implication for studying novel therapies. Clin Infect DIS. 2010;51:1273–1280.
- Gimenia C, Guerrisi P, Frustaci AM, et al. New category of probable invasive pulmonary aspergillosis in haematological patients. Clin Microbiol Infect. 2012;18:990–996.
- Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–829.
- Eigl S, Hoenigl M, Spiess B, et al. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis. Med Mycol 2016. [Epub ahead of print]. doi: 10.1093/mmy/myw102
- Zhang S, Wang S, Wan Z, et al. Quantitative real-time PCR and platelia galactomannan assay for the diagnosis of invasive pulmonary aspergillosis: bronchoalveolar lavage fluid performs better than serum in non-neutropenic patients. Mycopathologia. 2016;181:625–629.
- Lahmer T, Neuenhahn M, Held J, et al. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunuppressed mechanical ventilated critically ill patients. J Crit Care. 2016;36:259–264.